US9603796 — Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Method of Use · Assigned to Otonomy Inc · Expires 2029-04-21 · 3y remaining
What this patent protects
This patent protects methods and compositions for treating otic diseases or conditions using antimicrobial agents applied directly to the affected area.
USPTO Abstract
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Drugs covered by this patent
- Cipro (Ciprofloxacin) · Alk Abello
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-2252 |
— | Cipro |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.